Recent progress in the treatment of cancer in children

…, K Ludwig, HL Pacenta, LJ Klesse… - CA: a cancer journal …, 2021 - Wiley Online Library
Although significant improvements have been made in the outcomes of children with cancer,
the pace of improvement has slowed in recent years as the limits of therapy intensification …

Trks: signal transduction and intracellular pathways

LJ Klesse, LF Parada - Microscopy research and technique, 1999 - Wiley Online Library
The neurotrophin family of growth factors supports survival and differentiation of neurons in
the developing vertebrate nervous system by binding activating receptor tyrosine kinases, …

MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus

…, BD Gelb, D Hargrave, AR Kim, LJ Klesse… - Neuro …, 2022 - academic.oup.com
The wide variety of clinical manifestations of the genetic syndrome neurofibromatosis type 1
(NF1) are driven by overactivation of the RAS pathway. Mitogen-activated protein kinase …

Mouse tumor model for neurofibromatosis type 1

KS Vogel, LJ Klesse, S Velasco-Miguel, K Meyers… - Science, 1999 - science.org
Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder characterized by increased
incidence of benign and malignant tumors of neural crest origin. Mutations that activate …

Requirement for nitric oxide activation of p21ras/extracellular regulated kinase in neuronal ischemic preconditioning

…, AB Feldman, LJ Klesse… - Proceedings of the …, 2000 - National Acad Sciences
The mechanisms underlying neuronal ischemic preconditioning, a phenomenon in which brief
episodes of ischemia protect against the lethal effects of subsequent periods of prolonged …

Nerve growth factor induces survival and differentiation through two distinct signaling cascades in PC12 cells

LJ Klesse, KA Meyers, CJ Marshall, LF Parada - Oncogene, 1999 - nature.com
Nerve growth factor induces differentiation and survival of rat PC12 pheochromocytoma
cells. The activation of the erk cascade has been implicated in transducing the multitude of …

[HTML][HTML] Clinical outcomes and patient-matched molecular composition of relapsed medulloblastoma

…, G Fleischhack, G Dhall, LJ Klesse… - Journal of Clinical …, 2021 - ncbi.nlm.nih.gov
Klesse, MD, PhD, 8 Sarah Leary, MD, 23 Javad Nazarian, PhD, 24 Marcel Kool, PhD, 25
Pieter Wesseling, MD, 26 Marina Ryzhova, MD, 27 Olga Zheludkova, MD, 28 Andrey V …

The use of MEK inhibitors in neurofibromatosis type 1–associated tumors and management of toxicities

LJ Klesse, JT Jordan, HB Radtke, T Rosser… - The …, 2020 - academic.oup.com
Neurofibromatosis type 1 (NF1) clinical care is on the cusp of a transformative shift. With the
success of recent clinical trials using MEK inhibitors, an increasing number of NF1 patients …

p21 ras and phosphatidylinositol-3 kinase are required for survival of wild-type and NF1 mutant sensory neurons

LJ Klesse, LF Parada - Journal of Neuroscience, 1998 - Soc Neuroscience
Nerve growth factor (NGF) is a required differentiation and survival factor for sympathetic and
a majority of neural crest-derived sensory neurons in the developing vertebrate peripheral …

Activation of Ras is necessary and sufficient for upregulation of vanilloid receptor type 1 in sensory neurons by neurotrophic factors

R Bron, LJ Klesse, K Shah, LF Parada… - Molecular and Cellular …, 2003 - Elsevier
We have analyzed signaling pathways involved in neurotrophic factor (NTF)-induced
upregulation of nociceptive properties, specifically vanilloid receptor type 1 (VR1), by adult rat …